27Dec 2022
Treatment outcomes and cost comparisons for older adults with T4 laryngeal squamous cell cancer

Treatment outcomes and cost comparisons for older adults with T4 laryngeal squamous cell cancer

To evaluate treatment modalities of T4 larynx cancer in older adults using SEER‐Medicare. Older patients with T4 larynx cancer had similar survival rates when treated with CR, SR, and SCR. Average total health care costs were not significantly different between modalities. Patients not eligible for triple‐modality could consider these other treatment options.

  • #ent

Like

Save

Share